"The deal pipeline continues to be robust with multiple large deal opportunities as customers seek productivity and efficiency improvement. We reaffirm our USD revenue growth guidance of 17.5 per cent-18.5 per cent in constant currency," he said in the investor presentation. Among verticals, medical devices grew 2.4 per cent sequentially, while telecom and hi-tech witnessed a growth of 1 per cent during this period. All its five verticals showed positive growth in this period. Among geographies, while North America witnessed a degrowth of 0.4 per cent, Europe saw a growth of 6.4 per cent over the previous quarter. Despite the good performance, LTTS' headcount fell by 582 to 23,298 employees by the end of December quarter. Its attrition fell to 15.8 per cent from 16.7 per cent reported in the previous quarter.